Pulsenmore starts US operations after FDA authorization, revenue rises 53%
AI Summary- Pulsenmore Ltd. began commercial operations in the United States after FDA authorization.
- Revenue increased 53%, according to the company.
- Pulsenmore recorded its first patient scan in early 2026.